ukmla MCQ (SBA): COPD pharmacotherapy

Instant feedback + full explanation. One question, done properly.

MediumRespiratoryCOPD pharmacotherapyukmlamrcgp aktpanemrcp part 1prescribing safety assessment

A 68-year-old ex-smoker has FEV1 58% predicted and mMRC dyspnoea score of 2 despite tiotropium. Two exacerbations in the last year. What is the next step?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.

ukmla MCQ: COPD pharmacotherapy — Answer & Explanation | iatroX